IRIS
POMPILIO, ARIANNA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.700
EU - Europa 4.420
AS - Asia 3.862
Continente sconosciuto - Info sul continente non disponibili 676
SA - Sud America 449
AF - Africa 68
OC - Oceania 5
Totale 16.180
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.562
SG - Singapore 1.672
RU - Federazione Russa 1.095
CN - Cina 985
IT - Italia 806
IE - Irlanda 533
GB - Regno Unito 437
SE - Svezia 399
UA - Ucraina 395
BR - Brasile 347
VN - Vietnam 341
TR - Turchia 294
DE - Germania 219
FR - Francia 206
IN - India 173
HK - Hong Kong 98
FI - Finlandia 89
CA - Canada 66
BD - Bangladesh 58
JP - Giappone 46
MX - Messico 42
ES - Italia 39
IQ - Iraq 39
NL - Olanda 38
AT - Austria 34
AR - Argentina 31
PL - Polonia 29
ZA - Sudafrica 26
CH - Svizzera 22
CO - Colombia 19
EC - Ecuador 19
BE - Belgio 17
KR - Corea 16
SA - Arabia Saudita 14
VE - Venezuela 13
CZ - Repubblica Ceca 12
MY - Malesia 12
MA - Marocco 11
PH - Filippine 11
PK - Pakistan 11
ID - Indonesia 10
LB - Libano 10
UZ - Uzbekistan 10
IL - Israele 9
IR - Iran 8
EU - Europa 7
JO - Giordania 7
KE - Kenya 7
LT - Lituania 7
TH - Thailandia 7
JM - Giamaica 6
PY - Paraguay 6
RS - Serbia 6
TN - Tunisia 6
AE - Emirati Arabi Uniti 5
CL - Cile 5
CR - Costa Rica 5
GR - Grecia 5
KZ - Kazakistan 5
PE - Perù 5
AZ - Azerbaigian 4
BY - Bielorussia 4
DK - Danimarca 4
HN - Honduras 4
PT - Portogallo 4
UY - Uruguay 4
AL - Albania 3
AO - Angola 3
CI - Costa d'Avorio 3
DZ - Algeria 3
HR - Croazia 3
NP - Nepal 3
OM - Oman 3
PA - Panama 3
RO - Romania 3
SY - Repubblica araba siriana 3
AU - Australia 2
BG - Bulgaria 2
BH - Bahrain 2
CG - Congo 2
EE - Estonia 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
SC - Seychelles 2
SN - Senegal 2
SV - El Salvador 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BS - Bahamas 1
BZ - Belize 1
DO - Repubblica Dominicana 1
EG - Egitto 1
ET - Etiopia 1
GD - Grenada 1
GE - Georgia 1
HU - Ungheria 1
KG - Kirghizistan 1
KW - Kuwait 1
LU - Lussemburgo 1
Totale 15.501
Salva come PNG Salva come JPEG
Città #
Singapore 1.229
Chandler 835
San Jose 741
Jacksonville 553
Dublin 527
Ashburn 460
Dallas 328
Beijing 283
Dearborn 281
Princeton 252
Council Bluffs 245
Southend 208
Los Angeles 206
Chieti 163
Nanjing 150
Izmir 142
Santa Clara 131
Wilmington 95
New York 93
Ho Chi Minh City 91
The Dalles 90
Hong Kong 87
Ann Arbor 79
Cambridge 74
Hanoi 70
Altamura 68
Buffalo 62
Pescara 59
Tongling 58
Moscow 53
Nanchang 48
Boardman 47
Dong Ket 42
Washington 42
Munich 41
Redondo Beach 41
São Paulo 41
Rome 39
Orem 37
Tokyo 35
Phoenix 33
Vienna 30
Columbus 27
Kunming 27
Milan 27
Chicago 26
Hebei 25
Montreal 25
Brooklyn 24
Hefei 24
Shenyang 24
Warsaw 23
Chennai 22
Jiaxing 22
Norwalk 22
Woodbridge 22
Amsterdam 21
Frankfurt am Main 21
Nuremberg 21
Atlanta 20
Tianjin 20
Houston 19
Da Nang 18
Johannesburg 18
Civitanova Marche 17
Denver 17
Mexico City 17
Boston 16
Brussels 16
Poplar 16
San Francisco 16
Stockholm 16
Ancona 15
Baghdad 15
Teramo 15
Mumbai 14
Ankara 13
Haiphong 13
Pune 13
Shanghai 13
Toronto 13
Falls Church 12
Seattle 12
Changsha 11
London 11
Memphis 11
Rio de Janeiro 11
Augusta 10
Kocaeli 10
Palermo 10
Guangzhou 9
Helsinki 9
Manchester 9
Newark 9
Seoul 9
Varallo 9
Ferrara 8
Kuala Lumpur 8
Zurich 8
Belo Horizonte 7
Totale 9.125
Salva come PNG Salva come JPEG
Nome #
Adhesion and biofilm formation by Staphylococcus aureus clinical isolates under conditions relevant to the host: Relationship with macrolide resistance and clonal lineages 861
Identification, antimicrobial resistance and molecular characterization of the human emerging pathogen Streptococcus gallolyticus subsp. pasteurianus 223
Corynebacterium glucuronolyticum causing genitourinary tract infection: Case report and review of the literature 199
Attività battericida ed anti-biofilm di peptidi antimicrobici verso patogeni multi-resistenti isolati da pazienti con fibrosi cistica. 189
Efficacy of phages and antibiotic-phage combinations against biofilm by Pseudomonas aeruginosa from cystic fibrosis patients 178
Fatal sepsis by Klebsiella pneumoniae in a patient with systemic lupus erythematosus: the importance of postmortem microbiological examination for the ex post diagnosis of infection. 169
An overview on streptococcus bovis/streptococcus equinus complex isolates: Identification to the species/subspecies level and antibiotic resistance 167
Cooperative pathogenicity in cystic fibrosis: Stenotrophomonas maltophilia modulates Pseudomonas aeruginosa virulence in mixed biofilm 165
Colonic adenoma-associated Escherichia coli express specific phenotypes 162
Antibiotic resistance and biofilm in Stenotrophomonas maltophilia isolates from cystic fibrosis and non-cystic fibrosis patients 160
Adhesion to and biofilm formation on IB3-1 bronchial cells by Stenotrophomonas maltophilia isolates from cystic fibrosis patients. 159
Phylogenetic relationships, biofilm formation, motility, antibiotic resistance and extended virulence genotypes among Escherichia coli strains from women with community-onset primitive acute pyelonephritis 154
A novel biotechnology product for the degradation of biofilm-associated polysaccharides produced by Streptococcus mutans 153
Analisi proteomica del biofilm formato da un ceppo di Stenotrophomonas maltophilia isolato da fibrosi cistica. 152
Helicobacter pylori ATCC 43629/NCTC 11639 Outer Membrane Vesicles (OMVs) from Biofilm and Planktonic Phase Associated with Extracellular DNA (eDNA). 152
A new challenge in cystic fibrosis antimicrobial therapy: activity of electrochemically synthesized silver nanoparticles against planktonic and biofilm cells of bacterial pathogens 149
In vitro microbiology studies on a new peritoneal dialysis connector 145
Peptide dendrimers as “lead compounds” for the treatment of chronic lung infections by Pseudomonas aeruginosa in cystic fibrosis patients: In vitro and in vivo studies 143
Identification, antimicrobial resistance and molecular characterization of the human emerging pathogen Streptococcus gallolyticus subsp pasteurianus 139
An overview of various typing methods for clinical epidemiology of the emerging pathogen Stenotrophomonas maltophilia. 138
Effect of levofloxacin on Stenotrophomonas maltophilia biofilm and its relationship with SmeDEF multidrug efflux pump expression under conditions relevant to the cystic fibrosis lung 138
Meticillin-heteroresistant Staphylococcus pasteuri from an apheresis platelet product 137
Characterization of biofilm formation by Myroides odoratimimus isolated from post-traumatic calcaneal recurrent ulcer in diabetic patient 137
Alterazione dei livelli tessutali di ioni metallici in un modello murino di infezione polmonare da Stenotrophomonas maltophilia. 136
Role of excessive inflammatory response to Stenotrophomonas maltophilia lung infection in DBA/2 mice and implications for cystic fibrosis. 135
Giving Drugs a Second Chance: Antibacterial and Antibiofilm Effects of Ciclopirox and Ribavirin against Cystic Fibrosis Pseudomonas aeruginosa Strains 134
In vitro and in vivo evaluation of BMAP-derived peptides for the treatment of cystic fibrosis-related pulmonary infections 133
Evaluation of antibacterial and antibiofilm mechanisms by usnic acid against methicillin-resistant Staphylococcus aureus 132
Microbial cooperation in cystic fibrosis: Stenotrophomonas maltophilia significantly modulates Pseudomonas aeruginosa virulence. 132
Helicobacter pylori Outer Membrane Vesicles (OMVs) as DNA shuttles and structural components of biofilm EPS 131
New insights in Staphylococcus pseudintermedius pathogenicity: antibiotic-resistant biofilm formed by a human wound-associated strain. 130
Effect of environmental factors on biofilm formation by clinical Stenotrophomonas maltophilia strains. 128
Development of a nanocomposite membrane based on reduced graphene (r-GO) and zeolite 13X for the removal of metal ions with bactericidal actions 128
Staphylococcus pasteuri bacteraemia in a patient with leukaemia. 127
Anaerobiosi ed ambiente acido influenzano l’attività in vitro di colistina nei confronti del biofilm formato da ceppi di Pseudomonas aeruginosa isolati da pazienti affetti da fibrosi cistica. 127
A cystic fibrosis child with lung function decline 126
null 125
Misidentification of ampicillin-sulbactam heteroresistance in Acinetobacter baumannii strains from ICU patients 123
Normal breathing releases SARS-CoV-2 into the air 123
Pan-azole-resistant Candida guilliermondii from a leukemia patient's silent funguria 122
In vitro and in vivo evaluation of BMAP-derived peptides for the treatment of cystic fibrosis-related pulmonary infections 122
Effetto di concentrazioni sub-inibenti di moxifloxacina su Stenotrophomonas maltophilia isolati da fibrosi cistica 120
Evolution of Stenotrophomonas maltophilia in Cystic Fibrosis Lung over Chronic Infection: A Genomic and Phenotypic Population Study 120
Hafnia alvei from the farm to the delivery room 119
Determination of ciprofloxacin and levofloxacin in human sputum collected from cystic fibrosis patients using microextraction by packed sorbent-high performance liquid chromatography photodiode array detector 118
Serum and mucosal cytokine profiles in patients with active Helicobacter pylori and ischemic heart disease: is their a relationship ? 117
Subinhibitory concentrations ofmoxifloxacin decrease adhesion and biofilm formation of Stenotrophomonasmaltophilia from cystic fibrosis. 117
In vitro bactericidal and antibiofilm activity of six antimicrobial peptides against multidrug-resistant pathogens from patients with cystic fibrosis. 117
Disomeostasi cationica in un modello murino di infezione polmonare da Stenotrophomonas maltophilia 117
Exposure to extremely low-frequency magnetic field affects biofilm formation by cystic fibrosis pathogens 117
Cell surface hydrophobicity, motility, and biofilm formation of Stenotrophomonas maltophilia clinical isolates. 116
Risk of misidentification of Enterobacter aerogenes inducible cephalosporinases. 116
Stenotrophomonas maltophilia virulence and specific variations in trace elements during acute lung infection: implications in cystic fibrosis. 115
Stenotrophomonas maltophilia Phenotypic and Genotypic Diversity during a 10-year Colonization in the Lungs of a Cystic Fibrosis Patient 115
An antimicrobial bicyclic peptide from chemical space against multidrug resistant Gram-negative bacteria 115
Isolation of colistin-resistant Hafnia alvei. 114
In vivo bacterial cooperation in cystic fibrosis: exposure to Stenotrophomonas maltophilia affects Pseudomonas aeruginosa virulence in murine model of acute lung infection. 114
In vitro activity of multi-branched peptides against planktonic and biofilm cells of Pseudomonas aeruginosa from cystic fibrosis patients. 114
In vitro activity of colistin against biofilm by Pseudomonas aeruginosa is significantly improved under "cystic fibrosis-like" physicochemical conditions 114
In vitro activity of levofloxacin against planktonic and biofilm Stenotrophomonas maltophilia lifestyles under conditions relevant to pulmonary infection in cystic fibrosis, and relationship with SmeDEF multidrug efflux pump expression 114
Myroides odoratimimus Forms Structurally Complex and Inherently Antibiotic-Resistant Biofilm in a Wound-Like in vitro Model. 113
Factors associated with adherence to and biofilm formation on polystyrene byStenotrophomonas maltophilia: the role of cell surface hydrophobicity and motility. 112
D-BMAP18 Antimicrobial Peptide Is Active In vitro, Resists to Pulmonary Proteases but Loses Its Activity in a Murine Model of Pseudomonas aeruginosa Lung Infection 112
Infection of recurrent calcaneal ulcer caused by a biofilm-producer Myroides odoratimimus strain. 112
Antibacterial and anti-biofilm effects of cathelicidin peptides against pathogens isolated from cystic fibrosis patients. 112
Antimicrobial and antibiofilm activity of secondary metabolites of lichens against methicillin-resistant Staphylococcus aureus strains from cystic fibrosis patients. 110
Stenotrophomonas maltophilia mutant lacking flagella remains virulent in DBA/2N mice but is less efficient in stimulating TNF-α expression 109
Antidiabetic “gliptins” affect biofilm formation by Streptococcus mutans 109
An ultrathin film membrane based on a nano-channeled reduced graphene oxide with enhanced antibacterial properties 108
Eparina sodica stimola la formazione di biofilm da parte di Providencia stuartii. 107
V240H replacement, by site-directed mutagenesis, increases resistance toward carbapenems in TEM-149 ESBL producing E. coli. 106
Determinazione di Ciprofloxacina e Levofloxacina in espettorato da pazienti affetti da fibrosis cistica mediante MEPS-HPLC-PDA 105
Identification of CTX-M-15 and CTX-M-27 in Antibiotic-Resistant Gram-Negative Bacteria Isolated from Three Rivers Running in Central Italy 105
Phenotypic and genotypic characterization of Stenotrophomonas maltophilia isolates from patients with cystic fibrosis: genome diversity, biofilm formation, and virulence. 103
Tuberculosis-like pneumonias by the aerobic actinomycetes Rhodococcus, Tsukamurella and Gordonia. 103
Modulation of biofilm formation by Stenotrophomonas maltophilia during chronic lung infection in cystic fibrosis patients: a longitudinal population study 102
Electrochemically Synthesized Silver Nanoparticles Are Active Against Planktonic and Biofilm Cells of Pseudomonas aeruginosa and Other Cystic Fibrosis-Associated Bacterial Pathogens 101
Potential novel therapeutic strategies in cystic fibrosis: antimicrobial and anti-biofilm activity of natural and designed α-helical peptides against Staphylococcus aureus, Pseudomonas aeruginosa, and Stenotrophomonas maltophilia. 101
New insights in Staphylococcus pseudintermedius pathogenicity: Antibiotic-resistant biofilm formation by a human wound-associated strain 101
Clonal diversity, biofilm formation, and antimicrobial resistance among Stenotrophomonas maltophilia strains from cystic fibrosis and non-cystic fibrosis patients 101
Comparative evaluation of the Vitek-2 Compact and Phoenix systems for rapid identification and antibiotic susceptibility testing directly from blood cultures of Gram-negative and Gram-positive isolates. 100
ONE-STEP DEPOSITION METHOD FOR THE SYNTHESIS OF A NANOCOMPOSITE MEMBRANE BASED ON REDUCED GRAPHENE OXIDE/ZEOLITE-A FOR ADSORPTION OF METAL IONS WITH ENHANCED ANTIBACTERIAL PROPERTIES 99
Toward optimization of antimicrobial peptides for the treatment of multidrug resistant infections in cystic fibrosis. 99
Molecular genotyping, adhesion and biofilm formation in methicillin-resistant Staphylococcus aureus clinical strains. 98
Comparative Proteomic Analysis of Protein Patterns of Stenotrophomonas maltophilia in Biofilm and Planktonic Lifestyles 97
“Indirect pathogenicity” in cystic fibrosis during pulmonary exacerbations: Stenotrophomonas maltophilia modulates Pseudomonas aeruginosa virulence in a Galleria mellonella model. 97
Olive Pâté by Multi-Phase Decanter as Potential Source of Bioactive Compounds of Both Nutraceutical and Anticancer Effects 97
Electrochemically synthesized silver nanoparticles are active against planktonic and biofilm cells of Pseudomonas aeruginosa and other cystic fibrosis-associated bacterial pathogens 97
Chloramphenicol and rifampin may be the only options against Stenotrophomonas maltophilia. A tale of a colonized bladder device in a patient with myelofibrosis. 96
Patogenesi in fibrosi cistica: clearance di Stenotrophomonas maltophilia ed infiammazione in un modello murino di infezione polmonare. 95
Ruolo epidemiologico del biofilm in isolati di Stenotrophomonas maltophilia da pazienti con fibrosi cistica e da pazienti ricoverati in unità di terapia intensiva 95
Anti-inflammatory strategies to tackle Pseudomonas aeruginosa lung infections: exploring the potential of the antimicrobial peptide lin-SB056-1 and its dendrimeric derivative 95
SURFACOME CHANGES of METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS IN BACTERIAL GROWTH UNDERGOING USNIC TREATMENT BY PROTEOMIC APPROACH 95
Attvità antibatterica ed anti-biofilm del peptide P19(9/B) verso isolati multi-resistenti isolati da pazienti affetti da fibrosi cistica 94
Individuation and evaluation of new bacteriophages for the treatment of cystic fibrosis biofilm-related lung infections caused by Pseudomonas aeruginosa. 94
Repurposing High-Throughput Screening Reveals Unconventional Drugs with Antimicrobial and Antibiofilm Potential Against Methicillin-Resistant Staphylococcus aureus from a Cystic Fibrosis Patient 93
Antibacterial and Antibiofilm Effects of Lactobacilli Strains against Clinical Isolates of Pseudomonas aeruginosa under Conditions Relevant to Cystic Fibrosis 93
Multidrug-resistant Geotrichum capitatum from a haematology ward. 93
In vitro bactericidal and anti-biofilm activity of bovine myeloid antimicrobial peptides against multidrug-resistant bacteria from patients with cystic fibrosis. 93
Studio microbiologico in vitro su di un nuovo connettore per dialisi peritoneale 93
Totale 12.937
Salva come PNG Salva come JPEG
Categoria #
all - tutte 64.296
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 64.296
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022762 0 0 31 121 60 22 35 62 85 20 94 232
2022/20232.073 179 270 156 248 184 384 105 152 254 25 83 33
2023/2024918 61 50 79 33 80 250 194 47 12 25 8 79
2024/20252.122 119 360 245 73 54 109 108 102 283 103 256 310
2025/20265.670 364 187 544 522 570 241 946 343 1.117 455 291 90
2026/2027672 249 279 144 0 0 0 0 0 0 0 0 0
Totale 16.180